Earnings Call · Q2 FY2023·2023-08-09

Q2 23EPS -25.00%·Rev n/aQ1 23EPS -3.57%·Rev n/aQ4 22EPS +22.45%·Rev n/aQ3 22EPS +8.57%·Rev n/a⚠ consensus missing

AVANOS MEDICAL, INC. AVNS

Joe Woody — Chief Executive Officer (CEO)

Scott Galovan — Investor Relations or Communications

Michael Greiner — Senior Vice President, Chief Financial Officer (CFO) and Chief Transformation Officer

−1.5%1d on move date−0.8% vs SPY3d−5.1%5d−6.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AVNS calls or request research access.

More AVNS calls Browse calls Request research access